Pasar al contenido principal

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publicación Artículo científico (JournalArticle)

Personalized cancer therapy prioritization based on driver alteration co-occurrence patterns

  • Mateo, Lidia
  • Duran-Frigola, Miquel
  • Gris-Oliver, Albert|||0000-0003-1802-9541
  • Palafox, Marta|||0000-0002-1762-3250
  • Scaltriti, Maurizio|||0000-0002-5522-1447
  • Razavi, Pedram
  • Chandarlapaty, Sarat
  • Arribas, Joaquín V.|||0000-0002-0504-0664
  • Bellet Ezquerra, Meritxell|||0000-0001-8859-8307
  • Serra, Violeta|||0000-0001-6620-1065
  • Aloy, Patrick|||0000-0002-3557-0236
Identification of actionable genomic vulnerabilities is key to precision oncology. Utilizing a large-scale drug screening in patient-derived xenografts, we uncover driver gene alteration connections, derive driver co-occurrence (DCO) networks, and relate these to drug sensitivity. Our collection of 53 drug-response predictors attains an average balanced accuracy of 58% in a cross-validation setting, rising to 66% for a subset of high-confidence predictions. We experimentally validated 12 out of 14 predictions in mice and adapted our strategy to obtain drug-response models from patients' progression-free survival data. Our strategy reveals links between oncogenic alterations, increasing the clinical impact of genomic profiling.